Highly Accessed Meeting report

Epigenomics and chromatin dynamics

Veronika Akopian1†, Michelle M Chan2†, Kendell Clement1†, Christina Galonska1†, Casey A Gifford1†, Elizabeth Lehtola1†, Jing Liao1†, Payman Samavarchi-Tehrani1†, Camille Sindhu1†, Zachary D Smith1†, Alexander M Tsankov1†, Jamie Webster1†, Yingying Zhang1†, Michael J Ziller1† and Alexander Meissner1*

Author Affiliations

1 Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA

2 Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, Massachusetts, 02139-4307 USA

For all author emails, please log on.

Genome Biology 2012, 13:313 doi:10.1186/gb-2012-13-2-313

Published: 24 February 2012

Abstract

A report of the 'Joint Keystone Symposium on Epigenomics and Chromatin Dynamics', Keystone, Colorado, 17-22 January 2012.

This year's Joint Keystone Symposium on Epigenomics and Chromatin Dynamics was one of the largest Keystone meetings to date, reflecting the excitement and many developments in this area. Richard Young opened the meeting by giving a historic overview before sharing more detailed insights from his recent work in describing the role of the lysine demethylase Lsd1 in mouse embryonic stem (ES) cell differentiation. He also set the broader stage and highlighted the excitement concerning recent advances in epigenetic drugs such as the new bromodomain inhibitors.